Neurocrine Biosciences
NBIX
#1579
Rank
NZ$22.82 B
Marketcap
NZ$228.93
Share price
1.15%
Change (1 day)
-15.05%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company